Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Afferon Corp.

www.afferon.com

Latest From Afferon Corp.

Do Corporate Alliances Affect Biotechs' Market Performance?

Is there a positive correlation between the number of corporate alliances biotechs have signed and their success at maintaining, or growing, their market valuations since their IPOs? To find out, we took the forty largest biotech IPOs completed in 1996 and 1997 and plotted their recent market valuations and percentage gain or loss over their IPO valuations against the number of significant corporate outlicensings they had signed since IPO.
BioPharmaceutical Leadership

Afferon Corp.

Afferon Corp.hopes to address the needs of patients suffering from urge incontinence with a drug (resiniferatoxin) that can be placed directly into the bladder with a urinary catheter.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Afferon Corp.
  • Senior Management
  • Terry Winters, PhD, CEO
    Spencer Johnson, VP, Corp. Dev.
    Hank Agersborg, MD, Chmn. & CSO
  • Contact Info
  • Afferon Corp.
    Phone: (610) 971-2555
    200 Eagle Rd.
    Wayne, PA 19087
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register